About the Author
My name is Mark Senak. I’m a lawyer and I work at the international communications firm FleishmanHillard in New York. For the past several years, I have been consulting with pharmaceutical and biologic companies that are engaged in the process of bringing new drugs to market. I have also worked extensively with an array of medical societies and patient organizations providing strategic communications counsel and media training.
Daily Archives: March 16, 2006
One Consequence of FDA Senate Hearings
There was lots of news of appointments at the FDA yesterday. In addition to the fact that Dr. Andrew C. von Eschenbach was formally nominated as Commissioner, David W. Boyer was appointed by Dr. von Eschenbach as the new head … Continue reading
Posted in Pharma Industry Image
Comments Off on One Consequence of FDA Senate Hearings